$3.04
-0.04-1.14%
At close: -
$3.09
0.051.64%
After Hours: Mar 24, 9:29 AM EDT
Comments
Loading...
Cosciens Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:CSCI | Benzinga
Cosciens Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-1.850
Quarterly Revenue
$1.90M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$7.60M
Analyze the earnings history of Cosciens Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSCI | Cosciens Biopharma | -$4.74 | — | — | — | $4.00K | — | — | — | 05/13/2025 | Get Alert |
| CSCI | AEterna Zentaris | -$4.64 | — | — | — | $121.00K | — | — | — | 04/11/2025 | Get Alert |
| CSCI | AEterna Zentaris | -$0.42 | — | -$1.85 | — | $2.00M | — | $1.90M | — | 11/12/2024 | Get Alert |
| CSCI | AEterna Zentaris | -$0.47 | — | -$0.64 | — | $1.40M | $1.10M | $2.30M | 109.09% | 08/13/2024 | Get Alert |
| CSCI | AEterna Zentaris | -$3.52 | -$3.24 | -$4.74 | -46.30% | $2.13M | $1.10M | $4.00K | -99.64% | 05/14/2024 | Get Alert |
| CSCI | Cosciens Biopharma | -$3.36 | -$3.88 | -$4.64 | -19.59% | $2.48M | — | $121.00K | — | 03/27/2024 | Get Alert |
| CSCI | Cosciens Biopharma | -$2.80 | -$2.44 | -$3.40 | -39.34% | $1.86M | $2.30M | $3.00K | -99.87% | 11/09/2023 | Get Alert |
| CSCI | Cosciens Biopharma | -$3.48 | -$3.48 | -$2.08 | 40.23% | -$222.00K | $1.14M | $2.25M | 97.02% | 08/09/2023 | Get Alert |
| CSCI | AEterna Zentaris | -$2.00 | -$3.48 | -$3.52 | -1.15% | $1.50M | $900.00K | $2.13M | 136.44% | 05/09/2023 | Get Alert |
| CSCI | AEterna Zentaris | -$2.00 | -$3.72 | -$3.36 | 9.68% | $1.00M | $1.06M | $2.48M | 134.43% | 03/23/2023 | Get Alert |
| CSCI | Cosciens Biopharma | -$1.00 | -$2.72 | -$2.80 | -2.94% | $602.00K | $1.33M | $1.86M | 39.85% | 11/03/2022 | Get Alert |
| CSCI | Cosciens Biopharma | -$2.00 | -$2.72 | -$3.48 | -27.94% | $599.00K | $1.31M | -$222.00K | -116.95% | 08/03/2022 | Get Alert |
| CSCI | Cosciens Biopharma | -$2.00 | -$2.00 | -$2.00 | 0.00% | $600.00K | $740.00K | $1.50M | 102.70% | 05/11/2022 | Get Alert |
| CSCI | Cosciens Biopharma | -$2.00 | -$2.00 | -$2.00 | 0.00% | $2.40M | $630.00K | $1.00M | 58.73% | 03/29/2022 | Get Alert |
| CSCI | Cosciens Biopharma | -$2.00 | -$2.00 | -$1.00 | 50.00% | $128.00K | $600.00K | $602.00K | 0.33% | 11/04/2021 | Get Alert |
| CSCI | Cosciens Biopharma | -$15.00 | — | -$2.00 | — | $68.00K | — | $599.00K | — | 08/04/2021 | Get Alert |
| CSCI | AEterna Zentaris | $4.00 | — | -$2.00 | — | $1.09M | — | $600.00K | — | 05/05/2021 | Get Alert |
| CSCI | Cosciens Biopharma | -$5.00 | — | -$2.00 | — | $18.00K | — | $2.40M | — | 03/25/2021 | Get Alert |
| CSCI | AEterna Zentaris | -$2.00 | — | -$2.00 | — | $283.00K | — | $128.00K | — | 11/06/2020 | Get Alert |
| CSCI | AEterna Zentaris | -$1.00 | — | -$15.00 | — | $194.00K | — | $68.00K | — | 08/06/2020 | Get Alert |
| CSCI | Cosciens Biopharma | -$30.00 | — | $4.00 | — | $37.00K | — | $1.09M | — | 05/06/2020 | Get Alert |
| CSCI | AEterna Zentaris | -$31.00 | — | -$5.00 | — | $1.40M | — | $18.00K | — | 03/30/2020 | Get Alert |
Cosciens Biopharma (CSCI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-14 | $-4.74 | $-3.24 | -46.3 % |
| Q4 | 2024-03-27 | $-4.64 | $-3.88 | -19.6 % |
| Q3 | 2023-11-09 | $-3.40 | $-2.44 | -39.3 % |
| Q2 | 2023-08-09 | $-2.08 | $-3.48 | 40.2 % |
Cosciens Biopharma (CSCI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-13 | $2.30M | $1.10M | 109.1 % |
| Q1 | 2024-05-14 | $4.00K | $1.10M | -99.6 % |
| Q3 | 2023-11-09 | $3.00K | $2.30M | -99.9 % |
| Q2 | 2023-08-09 | $2.25M | $1.14M | 97.0 % |
FAQ
When is Cosciens Biopharma (NASDAQ:CSCI) reporting earnings?
Cosciens Biopharma (CSCI) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Cosciens Biopharma (NASDAQ:CSCI)?
The Actual EPS was $-1.85, which missed the estimate of $0.00.
What were Cosciens Biopharma’s (NASDAQ:CSCI) revenues?
The Actual Revenue was $1.9M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.